CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
Gastric bypass +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00432809
NCT00432809N/ACompleted
CompareCT.gov

STAMPEDE: Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently

The Cleveland Clinic·interventional·Posted Feb 8, 2007·Updated Aug 23, 2017

In Brief

A clinical study evaluating Gastric bypass and Sleeve Gastrectomy for Diabetes Mellitus, Type 2 and Obesity. Completed, enrolled 150 participants across 1 site.

Detailed Summary

The aim of the study is to compare the relative clinical outcomes between advanced medical therapy alone or advanced medical therapy combined with bariatric surgery \[either Roux-en-Y gastric bypass (RYGBP) or laparoscopic sleeve gastrectomy\] in patients with type 2 diabetes and a body mass index (BMI) between 27 and 43 kg/m2. The study will examine the short and long term effects of each intervention on biochemical resolution of diabetes, diabetic complications, and end-organ damage.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2, Obesity
CountriesUnited States
CollaboratorsEthicon Endo-Surgery, LifeScan

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 8, 2007
Enrollment StartFeb 1, 2007
Primary CompletionFeb 1, 2016
Study CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 9 yearsPosted 19.4 years ago

Interventions

Gastric bypassprocedure

Roux-en-Y gastric bypass

Sleeve Gastrectomyprocedure

Laparoscopic sleeve gastrectomy